{
    "clinical_study": {
        "@rank": "6661", 
        "arm_group": [
            {
                "arm_group_label": "Exparel forearm block", 
                "arm_group_type": "Experimental", 
                "description": "Under ultrasound guidance, 3-5 mL Exparel will be injected around the 3 nerves of the forearm prior to surgery. 20-30 mL Mepivacaine will be used for the supraclavicular block following the forearm block."
            }, 
            {
                "arm_group_label": "Bupivacaine supraclavicular block", 
                "arm_group_type": "Active Comparator", 
                "description": "Under ultrasound guidance, 20-30 mL 0.5% Bupivacaine will be used for the supraclavicular block."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to compare Exparel, a new, long-lasting numbing medication and\n      a  shorter-acting nerve block to a traditional single-shot nerve block in patients having\n      hand, wrist or finger surgery."
        }, 
        "brief_title": "Study of A Long Lasting Local Anesthestic for Hand, Wrist or Finger Surgery", 
        "completion_date": {
            "#text": "February 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Hand Injuries", 
            "Wrist Injuries", 
            "Finger Injuries"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Finger Injuries", 
                "Hand Injuries", 
                "Wrist Injuries", 
                "Wounds and Injuries"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patients 18 years or older having hand, wrist, or finger surgery\n\n          -  ability to understand and provide informed consent\n\n          -  American Society of Anesthesiologists status I-III\n\n          -  presence of a responsible adult caregiver for 48-72 hours after surgery\n\n        Exclusion Criteria:\n\n          -  patient refusal or inability to provide informed consent\n\n          -  true allergy, not sensitivity to local anesthetics, midazolam, fentanyl,\n             hydromorphone, propofol\n\n          -  pregnancy\n\n          -  hepatic or renal failure\n\n          -  evidence of infection at or near the proposed needle insertion site\n\n          -  any sensorimotor deficit of the upper extremity\n\n          -  BMI greater than or equal to 35\n\n          -  uncontrolled or severe pulmonary disease\n\n          -  anticoagulant use (not aspirin or non-steroidal anti-inflammatories)\n\n          -  chronic pain patients"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "90", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 6, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02058303", 
            "org_study_id": "04262013"
        }, 
        "intervention": [
            {
                "arm_group_label": "Exparel forearm block", 
                "description": "20-30 mL Mepivacaine will be used for the supraclavicular block following the forearm block.", 
                "intervention_name": "Exparel Forearm block", 
                "intervention_type": "Drug", 
                "other_name": "bupivacaine liposome injectable suspension"
            }, 
            {
                "arm_group_label": "Bupivacaine supraclavicular block", 
                "description": "20-30mL 0.5% bupivacaine", 
                "intervention_name": "Bupivacaine supraclavicular block", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Bupivacaine"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "hand surgery", 
            "wrist surgery", 
            "finger surgery", 
            "anesthesia", 
            "regional anesthesia", 
            "postoperative pain"
        ], 
        "lastchanged_date": "February 6, 2014", 
        "location": {
            "contact": {
                "email": "jsoberon@ochsner.org", 
                "last_name": "Jose Soberon, MD", 
                "phone": "504-842-3755"
            }, 
            "facility": {
                "address": {
                    "city": "New Orleans", 
                    "country": "United States", 
                    "state": "Louisiana", 
                    "zip": "70121"
                }, 
                "name": "Ochsner Clinic Foundation"
            }, 
            "investigator": {
                "last_name": "Jose Soberon, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Exparel (Bupivacaine Liposome Injectable Suspension) for Distal Upper Extremity Blocks in Orthopedic Surgery", 
        "overall_contact": {
            "email": "jsoberon@ochsner.org", 
            "last_name": "Jose Soberon, MD", 
            "phone": "504-842-3755"
        }, 
        "overall_official": {
            "affiliation": "Ochsner Clinic Foundation", 
            "last_name": "Jose Soberon, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "February 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "A blinded study staff member will evaluate the subject after the block is performed. Subjects will be asked to move their hand and will be asked if they can feel a sharp sensation on specific areas of their hand. Once no movement and no feeling is detected, the block is considered successful and the time will be noted.", 
            "measure": "Onset of Sensorimotor block", 
            "safety_issue": "No", 
            "time_frame": "30 minutes"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02058303"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Ochsner Health System", 
            "investigator_full_name": "Jose Soberon, MD", 
            "investigator_title": "Anesthesiologist", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "source": "Ochsner Health System", 
        "sponsors": {
            "collaborator": {
                "agency": "Pacira Pharmaceuticals, Inc", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Jose Soberon, MD", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}